We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-7.87%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12B
AUM Growth
-$1.05B
Cap. Flow
+$29.7M
Cap. Flow %
0.25%
Top 10 Hldgs %
34.83%
Holding
1,447
New
32
Increased
612
Reduced
360
Closed
43

Sector Composition

Rank Sector Weight
1 Real Estate 59.18%
2 Technology 9.44%
3 Healthcare 4.32%
4 Consumer Discretionary 4.16%
5 Financials 4.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMVT icon
1201
Immunovant
IMVT
$7.93B
$2K ﹤0.01%
394
IPSC icon
1202
Century Therapeutics
IPSC
$364M
$2K ﹤0.01%
159
ITOS
1203
DELISTED
iTeos Therapeutics
ITOS
$2K ﹤0.01%
121
JANX icon
1204
Janux Therapeutics
JANX
$913M
$2K ﹤0.01%
121
MCRB icon
1205
Seres Therapeutics
MCRB
$45.3M
$2K ﹤0.01%
16
MIRM icon
1206
Mirum Pharmaceuticals
MIRM
$6.57B
$2K ﹤0.01%
89
MRSN
1207
DELISTED
Mersana Therapeutics
MRSN
$2K ﹤0.01%
10
MXCT icon
1208
MaxCyte
MXCT
$109M
$2K ﹤0.01%
293
NKTR icon
1209
Nektar Therapeutics
NKTR
$2.39B
$2K ﹤0.01%
36
NKTX icon
1210
Nkarta
NKTX
$152M
$2K ﹤0.01%
180
NRIX icon
1211
Nurix Therapeutics
NRIX
$2.45B
$2K ﹤0.01%
152
NUVL
1212
DELISTED
Nuvalent
NUVL
$2K ﹤0.01%
125
PGEN icon
1213
Precigen
PGEN
$1.94B
$2K ﹤0.01%
708
PMVP icon
1214
PMV Pharmaceuticals
PMVP
$57.1M
$2K ﹤0.01%
132
RAPT
1215
DELISTED
RAPT Therapeutics
RAPT
$2K ﹤0.01%
13
RPTX
1216
DELISTED
Repare Therapeutics
RPTX
$2K ﹤0.01%
127
-5,745
-98% -$74K
SGMO
1217
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2K ﹤0.01%
498
STOK icon
1218
Stoke Therapeutics
STOK
$1.84B
$2K ﹤0.01%
126
TBPH icon
1219
Theravance Biopharma
TBPH
$874M
$2K ﹤0.01%
215
TIL icon
1220
Instil Bio
TIL
$49.5M
$2K ﹤0.01%
19
VNDA icon
1221
Vanda Pharmaceuticals
VNDA
$304M
$2K ﹤0.01%
191
YMAB
1222
DELISTED
Y-mAbs Therapeutics
YMAB
$2K ﹤0.01%
149
KLRS
1223
Kalaris Therapeutics
KLRS
$80.4M
$2K ﹤0.01%
10
TVRD
1224
Tvardi Therapeutics
TVRD
$20.2M
$2K ﹤0.01%
5
GTHX
1225
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$2K ﹤0.01%
145

Similar funds

Daiwa Securities Group's Q3 2022 Portfolio in Review

As of Q3 2022, Daiwa Securities Group held 1,447 positions worth $12B, down 8% from $13.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group's Q3 2022 filing shows 32 new, 612 increased, 360 reduced and 43 closed positions. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 150,000 shares worth $7.43M. The largest sale was Duke Realty Corp., an estimated $243M.

By sector, the portfolio is most concentrated in Real Estate at 59% of assets, down from 61% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q3 2022 buy was NextEra Energy, Inc. 5.279% Corporate Units: 150,000 shares worth $7.43M.
  • Daiwa Securities Group added most to First Industrial Realty Trust in Q3 2022, an estimated $172M increase.
  • Daiwa Securities Group's biggest Q3 2022 reduction was Duke Realty Corp., cutting an estimated $243M.
  • Daiwa Securities Group fully exited Chefs' Warehouse in Q3 2022, selling an estimated $2.69M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $12B portfolio in Q3 2022.
  • Daiwa Securities Group opened 32 new positions and closed 43 in Q3 2022.
  • Daiwa Securities Group's portfolio value fell 8% quarter-over-quarter to $12B.

Based on Daiwa Securities Group's 13F filing for Q3 2022, filed 2 Nov 2022.